| Product Code: ETC313165 | Publication Date: Aug 2022 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Thailand artificial coma medically induced drug market is a niche segment within the pharmaceutical industry. These drugs are used to induce a state of artificial coma in patients, often for medical purposes such as controlling brain swelling after traumatic brain injuries or managing refractory seizures. While the market for such drugs is relatively small, it plays a crucial role in critical care and neurology. Advances in medical technology and research have led to the development of more effective and safer drugs for inducing artificial comas, and healthcare providers in Thailand are adopting these innovations to improve patient outcomes. The market is driven by the need for specialized medical interventions and the continuous pursuit of better treatment options for patients with severe neurological conditions.
The Thailand Artificial-coma-medically-induced-drug market is influenced by advancements in medical technology and critical care. These drugs are used to induce a controlled coma in patients with severe neurological conditions, such as traumatic brain injuries. As the healthcare infrastructure and expertise in critical care continue to improve, the demand for these drugs is increasing to enhance patient outcomes.
The Thailand Artificial Coma Medically Induced Drug Market encounters unique challenges, primarily related to medical ethics, patient consent, and regulations. Administering drugs to induce a medical coma involves complex decision-making and requires the utmost care to avoid adverse outcomes. The legal and ethical aspects of this practice are closely scrutinized, and healthcare providers must navigate a complex web of regulations and guidelines to ensure patient safety and rights. Balancing the benefits of artificial coma with the risks and costs involved presents a constant challenge in the medical field.
The market for medically induced artificial coma drugs in Thailand experienced fluctuations during the COVID-19 pandemic. These drugs are primarily used in critical care settings. While the pandemic increased the need for intensive care treatment, including medically induced comas for severe COVID-19 cases, supply chain challenges posed initial obstacles. Healthcare facilities faced shortages of essential drugs, including those used for artificial comas. The government and pharmaceutical companies worked together to ensure a stable supply. The market demonstrated adaptability in response to the unprecedented demand for critical care medications.
The Thailand market for medically-induced coma drugs is primarily served by pharmaceutical companies specializing in critical care medicines. Leading players include Sanofi S.A., Pfizer Inc., and AstraZeneca PLC. These companies provide a range of drugs and treatments used in inducing and managing medically induced comas, primarily for critical care patients in Thai hospitals.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Artificial-coma-medically-induced-drug Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Artificial-coma-medically-induced-drug Market - Industry Life Cycle |
3.4 Thailand Artificial-coma-medically-induced-drug Market - Porter's Five Forces |
3.5 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Artificial-coma-medically-induced-drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of critical illnesses requiring artificial coma induction |
4.2.2 Technological advancements in medical devices and drugs for inducing artificial coma |
4.2.3 Growing awareness and acceptance of medically induced coma as a treatment option |
4.3 Market Restraints |
4.3.1 Stringent regulations and ethical considerations surrounding the use of medically induced coma |
4.3.2 High cost associated with artificial coma induction and maintenance |
4.3.3 Risk of complications and adverse effects associated with prolonged coma duration |
5 Thailand Artificial-coma-medically-induced-drug Market Trends |
6 Thailand Artificial-coma-medically-induced-drug Market, By Types |
6.1 Thailand Artificial-coma-medically-induced-drug Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Drug Type, 2021-2031F |
6.1.3 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Propofol, 2021-2031F |
6.1.4 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Barbiturate, 2021-2031F |
6.2 Thailand Artificial-coma-medically-induced-drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Status Epilepticus, 2021-2031F |
6.2.3 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Stroke, 2021-2031F |
6.2.4 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Traumatic Brain Injury, 2021-2031F |
6.2.5 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Brain Infections, 2021-2031F |
6.2.6 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Drug Overdose, 2021-2031F |
6.2.7 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Others, 2021-2031F |
6.3 Thailand Artificial-coma-medically-induced-drug Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Thailand Artificial-coma-medically-induced-drug Market Revenues & Volume, By Drug Stores & Retail Pharmacies, 2021-2031F |
7 Thailand Artificial-coma-medically-induced-drug Market Import-Export Trade Statistics |
7.1 Thailand Artificial-coma-medically-induced-drug Market Export to Major Countries |
7.2 Thailand Artificial-coma-medically-induced-drug Market Imports from Major Countries |
8 Thailand Artificial-coma-medically-induced-drug Market Key Performance Indicators |
8.1 Average length of artificial coma duration |
8.2 Patient outcomes post artificial coma induction |
8.3 Rate of adoption of medically induced coma as a treatment option |
9 Thailand Artificial-coma-medically-induced-drug Market - Opportunity Assessment |
9.1 Thailand Artificial-coma-medically-induced-drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Thailand Artificial-coma-medically-induced-drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Thailand Artificial-coma-medically-induced-drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Artificial-coma-medically-induced-drug Market - Competitive Landscape |
10.1 Thailand Artificial-coma-medically-induced-drug Market Revenue Share, By Companies, 2024 |
10.2 Thailand Artificial-coma-medically-induced-drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here